Pharmacy
Conference Coverage
FDA’s Project Optimus aims to transform early cancer research
Q & A with an expert on how the FDA’s Project Optimus targets toxicity and how it could spell the end of traditional dose-escalation trials....
From the Journals
Oral cancer drugs requiring prior authorization on the rise
“Utilization management may be appropriate for some oncology drugs, such as those approved with provisional evidence of efficacy.”
News
FDA approves dasatinib for kids with Ph+ ALL
The U.S.
News
EC approves split dosing regimen for daratumumab
The European Commission (EC) has granted marketing authorization for a split dosing regimen for daratumumab (Darzalex®). The approval provides...
News
FDA approves first treatment for BPDCN
The U.S.
News
FDA approves ravulizumab for PNH
The U.S.
News
FDA approves calaspargase pegol-mknl for ALL
The U.S.
News
CHMP recommends treosulfan for allo-HSCT conditioning
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for treosulfan (Trecondi) as part...
News
CHMP backs lusutrombopag for severe thrombocytopenia
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for lusutrombopag to treat severe...
News
Long-acting interferon recommended for PV
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for ropeginterferon alfa-2b (...
News
CHMP backs dasatinib for kids with newly diagnosed ALL
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the marketing authorization for...